Aprea Therapeutics, Inc.
APRE
$1.59
-$0.0324-2.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.89M | -3.78M | -3.47M | -2.81M | -3.44M |
| Total Depreciation and Amortization | 5.40K | 5.40K | 5.30K | 6.20K | 5.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 86.80K | 184.60K | 134.00K | 29.70K | 161.50K |
| Change in Net Operating Assets | -708.40K | 1.13M | -310.90K | -1.16M | -462.90K |
| Cash from Operations | -3.51M | -2.47M | -3.64M | -3.94M | -3.74M |
| Capital Expenditure | 0.00 | 0.00 | -7.50K | -8.00K | -7.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | 0.00 | -7.50K | -8.00K | -7.20K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 140.80K | 0.00 | 0.00 | 16.00M | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -6.40K | -1.20K | -21.10K | -1.29M | 0.00 |
| Cash from Financing | 134.40K | -1.20K | -21.10K | 14.71M | 0.00 |
| Foreign Exchange rate Adjustments | -24.60K | 24.70K | -4.80K | -2.40K | 400.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.40M | -2.44M | -3.68M | 10.76M | -3.75M |